Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

[Drug utilization review--a practical example from primary care].

Schmidt-Mende K, Hasselström J.

Lakartidningen. 2013 May 29-Jun 4;110(22):1105-7. Swedish. No abstract available.

PMID:
23808084
2.

Reducing polypharmacy: evidence from a simple quality improvement initiative.

Little MO, Morley A.

J Am Med Dir Assoc. 2013 Mar;14(3):152-6. doi: 10.1016/j.jamda.2012.11.007. Epub 2012 Dec 25. No abstract available.

PMID:
23273343
3.

Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.

Lenander C, Elfsson B, Danielsson B, Midlöv P, Hasselström J.

Scand J Prim Health Care. 2014 Dec;32(4):180-6. doi: 10.3109/02813432.2014.972062. Epub 2014 Oct 27.

4.

Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.

Secoli SR, Figueras A, Lebrão ML, de Lima FD, Santos JL.

Drugs Aging. 2010 Sep 1;27(9):759-70. doi: 10.2165/11538460-000000000-00000.

PMID:
20809665
5.

Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews.

Fillit HM, Futterman R, Orland BI, Chim T, Susnow L, Picariello GP, Scheye EC, Spoeri RK, Roglieri JL, Warburton SW.

Am J Manag Care. 1999 May;5(5):587-94.

6.

Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population.

Leendertse AJ, de Koning GH, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts AC, van den Bemt PM.

J Clin Pharm Ther. 2013 Oct;38(5):379-87. doi: 10.1111/jcpt.12069. Epub 2013 Apr 26.

PMID:
23617687
7.

[Medication review of the polymedicated patient in primary care].

Flores Dorado M, Baena Parejo I, Jiménez Martín J, Faus Dáder MJ.

Aten Primaria. 2013 Apr;45(4):222-3. doi: 10.1016/j.aprim.2012.11.004. Epub 2013 Jan 3. Spanish. No abstract available.

8.

Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project.

Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, Roncaglioni C, Riva E, Lucca U, Bortolotti A, Fortino I, Merlino L.

Pharmacoepidemiol Drug Saf. 2011 May;20(5):488-96. doi: 10.1002/pds.2108. Epub 2011 Jan 24.

PMID:
21264988
9.

The moderating effect of medication review on polypharmacy and loneliness in older Chinese adults in primary care.

Liu BC, Chi I.

J Am Geriatr Soc. 2013 Feb;61(2):290-2. doi: 10.1111/jgs.12102. No abstract available.

PMID:
23405924
10.

Potential health impacts of multiple drug prescribing for older people: a case-control study.

Kadam UT.

Br J Gen Pract. 2011 Feb;61(583):128-30. doi: 10.3399/bjgp11X556263.

11.

Introduction of the Pill Pruner to acute medical care: a simple medication guide to control polypharmacy.

Chieng JH, Hughes L, Stewart A, Frampton CM, Hanger HC, Jardine DL.

Australas J Ageing. 2015 Mar;34(1):58-61. doi: 10.1111/ajag.12183. Epub 2015 Jan 12.

PMID:
25582847
12.

Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).

Wooten JM.

South Med J. 2015 Feb;108(2):97-104. doi: 10.14423/SMJ.0000000000000243. Review.

PMID:
25688894
13.

[Evaluation of potential drug interactions in primary health care prescriptions in Vitória da Conquista, Bahia (Brazil)].

Leão DF, de Moura CS, de Medeiros DS.

Cien Saude Colet. 2014 Jan;19(1):311-8. doi: 10.1590/1413-81232014191.2124. Portuguese.

14.
15.

Practical aspects of drug interactions in the pharmacotherapy in otolaryngology, or the seven cardinal sins of pharmacological treatment in otolaryngological practice.

Woroń J, Lorkowska-Zawicka B, Dobrowolska E, Serednicki W.

Otolaryngol Pol. 2016 May 24;70(4):1-9. doi: 10.5604/00306657.1205273.

PMID:
27387210
16.

Adverse drug reactions in the ICU: lessons learned.

Dubaybo BA, Dingell JD.

Chest. 2005 Sep;128(3):1100-1. No abstract available.

PMID:
16162692
17.

Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center.

LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM.

J Manag Care Pharm. 2006 Oct;12(8):677-85.

18.

Polypharmacy in the elderly: a literature review.

Fulton MM, Allen ER.

J Am Acad Nurse Pract. 2005 Apr;17(4):123-32. Review.

PMID:
15819637
19.

Frequency of medication errors in primary care patients with polypharmacy.

Koper D, Kamenski G, Flamm M, Böhmdorfer B, Sönnichsen A.

Fam Pract. 2013 Jun;30(3):313-9. doi: 10.1093/fampra/cms070. Epub 2012 Nov 6.

PMID:
23132894
20.

Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study.

Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R.

Drugs Aging. 2010 Jun 1;27(6):507-21. doi: 10.2165/11536650-000000000-00000.

PMID:
20524710

Supplemental Content

Support Center